We examined the production of regulated on activation normal T expressed and secreted (RANTES) chemokine, which may contribute to the recruitment and local accumulation of leukocytes in human preovulatory follicles. Cells were obtained from follicular aspirates collected from in vitro fertilization patients, then cultured. RANTES production in culture was measured by immunoenzymatic assay, RANTES-producing cells were measured by flow cytometry, and messenger ribonucleic acid as measured by RT-PCR and in situ hybridization. RANTES was detected in follicular fluids and culture supernatants; RANTES protein and messenger ribonucleic acid were expressed in granulosa cells. RANTES production was stimulated by tumor necrosis factor-␣ (TNF␣) and was inhibited in cultures containing a neutralizing anti-TNF␣ antibody. p55 TNF receptors were detected by RT-PCR and visualized on granulosa cells by flow cytometry. RANTES production was increased by phorbol 12-myristate 13-acetate, but not by 8-bromo-cAMP. RANTES was produced by granulosa cells from human preovulatory follicles. This production was activated by TNF␣, probably through TNF receptor p55. This suggests that RANTES may play an active role in ovarian processes involving the local accumulation of immune cells. (J Clin Endocrinol Metab 85: 417-424, 2000) 
expressed in granulosa cells. RANTES production was stimulated by tumor necrosis factor-␣ (TNF␣) and was inhibited in cultures containing a neutralizing anti-TNF␣ antibody. p55 TNF receptors were detected by RT-PCR and visualized on granulosa cells by flow cytometry. RANTES production was increased by phorbol 12-myristate 13-acetate, but not by 8-bromo-cAMP. RANTES was produced by granulosa cells from human preovulatory follicles. This production was activated by TNF␣, probably through TNF receptor p55. This suggests that RANTES may play an active role in ovarian processes involving the local accumulation of immune cells. (J Clin Endocrinol Metab 85: 417-424, 2000) T HE REPRODUCTIVE system is dependent on a variety of complex interactions that involve the immune and endocrine systems (1) . Ovulation has many features in common with inflammatory reactions, including the participation of leukocytes (2, 3) . The infiltration of macrophages and T cells into ovarian follicles is a cytological marker of the ovulatory process (4) . Just before ovulation, leukocytes penetrate to the area surrounding the leading follicle (5-7). Immediately after ovulation there is a rapid influx of macrophages and lymphocytes into the follicle. In human preovulatory follicles, these cells comprise 5-20% of follicular tissue cells (8, 9) . They may play an active role in the ovulation process. In the rat ovary, the addition of leukocytes to the perfusion medium significantly increases the number of LH-induced ovulations (10) . Leukocyte migration in and around the preovulatory follicle may be regulated through local chemokine modulation (11, 12) . Human preovulatory follicular fluid demonstrates chemotactic activity (13, 14) . Several chemoattractants are possible candidates for producing leukocyte recruitment in and around the follicle. IL-8 (15) , monocyte chemotactic protein-1 (16) , and growth-regulated oncogene ␣ (17) have been detected in human preovulatory follicles. Regulated on activation normal T expressed and secreted (RANTES) is another possible candidate. RANTES belongs to the ␤-chemokine subfamily (18) . It is involved in inflammatory responses and is considered an important mediator of inflammation (19) . It is a chemoattractant for memory T lymphocytes, monocytes/ macrophages, and eosinophils (20, 21) . RANTES is also a histamine-releasing factor capable of inducing histamine release from basophils and mast cells (22) . Through these various actions this chemokine may play a key role in the ovulatory process. In this study we measured the expression of RANTES in cultured human preovulatory follicle granulosa cells collected from patients undergoing in vitro fertilization, then cultured. To investigate how RANTES production is regulated, we tested the effect of tumor necrosis factor-␣ (TNF␣), a cytokine produced in human preovulatory follicles (23) which activates RANTES production (24, 25) . We also used pharmacological tools, such as 8-bromo-cAMP (8-BrcAMP), a permeable analog of cAMP, and phorbol 12-myristate 13-acetate (PMA), a phorbol ester that mimics the effect of diacylglycerol.
Material and Methods Reagents
DMEM-Ham's F-12 medium (vol/vol), trypsin-ethylenediamine tetraacetate (1 ϫ solution) were obtained from Life Technologies, Inc. (Cergy Pontoise, France). Percoll was purchased from Pharmacia (St. Quentin en Yvelines, France). Human recombinant TNF␣ (rhTNF␣) and neutralizing anti-TNF␣ were purchased from Genzyme (Cambridge, MA). 8-Br-cAMP and the phorbol ester PMA were obtained from SigmaAldrich Corp. (St. Quentin Fallavier, France). Kits for human RANTES immunoassays (Quantikine) were obtained from R&D Systems (Abington, UK). R-Phycoerythrin (R-PE)-conjugated mouse anti-human RANTES monoclonal antibody and the R-PE-conjugated mouse IgG1 isotype control, fluorescein isothiocyanate (FITC)-conjugated mouse antihuman CD45 monoclonal antibody, and the FITC-conjugated mouse IgG1 isotype control were purchased from PharMingen (San Diego, CA). Anti-TNF receptor p55 (htr-9) was provided by Dr. W. Leslauer and Hoffmann-La Roche. FITC-conjugated anti-mouse IgG was obtained from Immunotech (Marseille, France). Messenger ribonucleic acid (mRNA) capture kit, digoxigenin (DIG) RNA labeling mix, T3 and SP6 RNA polymerases, alkaline phosphatase-conjugated anti-DIG, and Fast Red tablets were purchased from Roche Molecular Biochemicals (Meylan, France).
Cell preparation
Cells were obtained from patients aged, 20 -40 yr, undergoing oocyte retrieval after ovarian stimulation for in vitro fertilization-embryo transfer (IVF-ET) according to routine protocols and selected at random. The experimental protocol and the use of the cells were submitted to patient consent. Cells from aspirates of multiple hyperstimulated preovulatory follicles were pooled and centrifuged through a Percoll cushion [vol/ vol, phosphate-buffered saline (PBS)-Percoll] to remove red blood cells, and then cultured in Ham's F-12-DMEM containing 15 mmol/L HEPES, 0.365 g/liter l-glutamine, 50 g/ml streptomycin, and 50 IU/ml penicillin, supplemented with 10% FCS. After an initial 24-h culture period, the medium plus floating cells were removed and replaced by medium containing 2% FCS. This was repeated every 24 h. Granulosa luteinizing cells were identified by their 3␤-hydroxysteroid dehydrogenase/⌬ 5 -⌬ 4 -isomerase (3␤HSD) activity, which metabolizes pregnenolone to form progesterone (26) . A positive reaction was observed under light microscope as black-blue precipitate within the cells.
Detection of RANTES production
Concentrations of RANTES were measured using a RANTES sandwich enzyme-linked immunosorbent assay (Quantikine kit, R&D Systems). The sensitivity of the test was 2.5 pg/ml. Assays were run in duplicate. Absorbance was measured at 450 nm. Intra-and interassay coefficients of variation were about 5% and 8%, respectively. Amounts of RANTES in culture supernatants were expressed per g protein to allow for changes in protein content reflecting cell number. At the end of the culture period, attached cells were dissolved in 0.5 n NaOH, the resulting solution was neutralized with 0.5 n HCl, and the protein concentration was measured using the Bio-Rad Laboratories, Inc. protein assay (Richmond, CA). Results were expressed as picograms of RANTES per g total protein/24 h.
Immunostaining and flow cytometric analysis
Cells were fixed with 2% (wt/vol) paraformaldehyde in PBS for 20 min at 4 C, permeabilized with 0.2% saponin in PBS for 5 min at 37 C, then exposed for 1 h at room temperature to R-PE-anti-RANTES antibody diluted at 8 g/ml in PBS containing 10% human serum AB and 0.2% saponin. R-PE-conjugated mouse IgG1 isotype was used as a control. The cells were washed repeatedly with PBS containing 0.2% saponin, then resuspended in PBS and stored at 4 C in the dark until read on the flow cytometer. Cells expressing membrane CD45 leukocyte antigen were visualized by exposure to saturated FITC-anti-CD45 antibody, which reacts with the 180-, 190-, 205-, and 220-kDa isoforms of the leukocyte antigen present on all human leukocytes. The cells were incubated with a 1:10 dilution of this antibody or with the control isotype FITC mouse IgG1 for 30 min on ice. They were then washed and resuspended in PBS until being read on the flow cytometer. TNF receptors (TNFR) were detected by incubation for 30 min at 4 C with 10 g/ml monoclonal anti-TNFR in PBS plus 10% human serum AB. The cells were washed repeatedly with PBS and then incubated for 30 min at 4 C with a 1:40 dilution of fluorescein-conjugated F(abЈ) 2 rabbit antimouse IgG. After successive washings in PBS, the cells were fixed with 2% (wt/vol) paraformaldehyde in PBS (20 min at 4 C) and then resuspended in PBS until they were read on the Becton Dickinson and Co. FACScan flow cytometer (Mountain View, CA). The flow cytometric data were analyzed using Becton Dickinson and Co. CellQuest software. The size and granulometry distribution of the cells were examined by simultaneous measurement of forward light scatter and side light scatter signals. Data for successive samples were acquired until 5,000 or 10,000 cells had accumulated in the gate. Fluorescence intensity histograms were generated vs. cell number. The percentage of cells that specifically bound to the test antibody was determined by subtracting the nonspecific fluorescence found for the isotype control from the total fluorescence found for the labeled antibody.
RNA extraction and PCR procedures
Polyadenylated mRNA was extracted from cell lysates, then hybridized with the biotin-labeled oligo(deoxythymidine) 20 probe and captured in streptavidin-coated PCR tubes using the mRNA capture kit from Roche Molecular Biochemicals according to the instructions of the manufacturer. The immobilized mRNA was directly transcribed into complementary DNA, then amplified using specific oligonucleotide primers with the sequences shown in Table 1 . The RT protocol was run at 50 C for 30 min, then at 94 C for 2 min. It was followed by the PCR amplification protocol run at 94 C for 1 min, 55 C for 1 min, and 72 C for 1 min for 30 cycles; the final extension step consisted of heating to 72 C for 10 min. The PCR products were separated on 2% agarose gel and visualized under UV after ethidium bromide staining.
In situ hybridization experiments
These experiments were performed on frozen cytocentrifuged cells as previously described (27) . In situ hybridization was performed with a RNA probe complementary to the coding sequence of human RANTES (28) . RNA probes were labeled with digoxigenin by in vitro transcription of DNA using DIG RNA labeling mix containing T3 polymerase for antisense probe and SP6 polymerase for sense probe (negative control). After acetylation, cell spots were hybridized overnight at 50 C with DIG RNA probes in a solution containing 50% (vol/vol) deionized formamide, 0.3 mol/L NaCl, 10 mmol/L Tris (pH 8.2), 1 mmol/L ethylenediamine tetraacetate, 0.05% yeast transfer RNA, 10 mmol/L dithiothreitol, 1 ϫ Denhardt's solution, and 10% dextran sulfate. The slides were treated with ribonuclease A (4 g/l) at 37 C for 30 min and then washed in buffers containing decreasing concentrations of salts. The digoxigenin label was detected by incubating the cells for 2 h at room temperature with alkaline phosphatase-conjugated anti-DIG antibody diluted 1:500 in a solution containing 1 mol/L NaCl, 0.1 mol/L Tris, 2 mmol/LMgCl 2 , 0.3% Triton X-100, and 3% normal sheep serum. Alkaline phosphatase was detected using Fast Red tablets as a substrate. The cells were counterstained with hematoxylin, mounted in glycerin/PBS, and observed under a light microscope. Brownish-red staining was indicative of positive binding by the RNA probe.
Results

Immunoreactive RANTES in follicular fluids and culture supernatants
The concentration of RANTES was measured in follicular fluid obtained from eight women undergoing in vitro fertilization 35-36 h after hCG administration. The mean concentration of RANTES was 174 Ϯ 12 pg/mL (n ϭ 8; Table 2 ). The cells were collected from the follicular aspirates and cultured at 10 5 cells/well. The supernatants were collected after 24 h, then attached cells were dissolved to measure protein concentration. The concentration of RANTES in culture supernatants was 29.6 Ϯ 2.5 pg/g total protein⅐24 h (n ϭ 8; Table 2 ).
Flow cytometric detection of RANTES-producing cells
The cells collected from the follicular aspirates were cultured at 10 5 cells/well for 24 -72 h. The size and granulom- ϩ cells (labeled with the anti-CD45 antibody) was examined in each experiment. Cells gated in region 1 (R1) did not contain CD45 ϩ cells. All cells that stained with an anti-CD45-FITC antibody were gated in region 2 (R2). The proportion of CD45 ϩ cells in R2 was always significantly lower in samples tested after 48 h in culture (Fig.  1) . We looked for the cells labeled with the RANTES antibody (RANTES ϩ cells) in R1 and R2. RANTES ϩ cells constituted about 40 -60% of the R1-gated cells. They were always less abundant in R2, although the proportion of CD45 ϩ cells varied from one sample to another one ( Table 3 ). The percentage of cells that stained positively for RANTES was highest during the first 24 h of culture. After 48 h in culture, the percentage of RANTES ϩ cells in R1 was slightly reduced, whereas it had slumped to less than 1% in R2. After 72 h, RANTES ϩ cells were still detected in R1, although their number had decreased (Fig. 2) . After 72 h, most of the cells contained 3␤HSD activity. Leukocytes had no 3␤HSD (our unpublished data).
Modulation of RANTES production
We tested the effect of TNF␣, a cytokine known to activate RANTES production (24, 25) . The effect of TNF␣ on RANTES production was tested by adding 1 ng/ml rhTNF␣ or 20 g/ml neutralizing anti-TNF␣ antibody, which blocks endogenous TNF␣ production, to the culture medium. We also investigated the effects of 1 mmol/L 8-Br-cAMP, a permeable analog of cAMP, and 50 nmol/L PMA, a phorbol ester that mimics the effect of diacylglycerol. Test reagents were added to the culture medium for 24 h, then medium was removed, and supernatants were collected and stored at Ϫ20 C until assayed. Cells were removed for protein assay. RANTES accumulation in cultures was measured in picograms of RANTES per g total protein/h. Treated cells were compared with untreated cells (control) in three separate experiments, with four replicate wells per treatment per experiment. The effects of treatments are expressed as the change in RANTES accumulation as a percentage of the untreated control value (100%). RANTES production was increased 5-fold by PMA and 2-fold by TNF␣ vs. the control value; it was decreased 2-fold by anti-TNF␣; 8-Br-cAMP had no significant effect (Fig. 3) . In three other separate experiments, cultured cells were removed after treatment, then stained a Attached cells were dissolved in 0.5 N NaOH, the resulting solution was neutralized with 0.5 N HCl, and the protein concentration was measured using the Bio-Rad protein assay. with specific Ab and analyzed by flow cytometry. The percentage of cells labeled with the RANTES antibody (RANTES ϩ cells) was measured in the R1-gated cells. rhTNF␣ slightly increased the number of cells staining for RANTES, whereas no cell stained for RANTES in cultures containing the neutralizing anti-TNF␣ antibody. PMA increased the percentage of RANTES ϩ cells, whereas 8-BrcAMP did not. Results were similar in the three experiments. Figure 4 shows a typical experiment of the three performed.
Detection of TNF receptors
TNFR were detected by RT-PCR and flow cytometry in cells cultured for 24 h. Amplification with TNFR p55 primers produced a single 477-bp amplicon. We measured the proportion of cells expressing TNFR by means of flow cytometry carried out after immunostaining with a p55 anti-TNFR antibody. Immunostaining for TNFR was strongly reinforced when neutralizing anti-TNF␣ was added to cultures. Under these conditions more than 40% of cells in R1 labeled for TNFR (Fig. 5) .
RANTES mRNA
RANTES mRNA was detected by RT-PCR. Amplification with RANTES primers produced a single 192-bp amplicon in cells that had been collected from follicular aspirates, suspended in culture medium for 2 h, and then cultured during 24 and 48 h (Fig. 6) . The cellular expression of RANTES mRNA was visualized in cells cultured for 24 h by in situ hybridization. In situ hybridization was performed using DIG-labeled human RANTES RNA probe. Red-colored cytoplasm indicated the presence of mRNA within individual cells. No colored cell was detected in controls using a sense RNA probe (Fig. 7) . The percentage of labeled cells actively synthesizing RANTES was determined visually; it was more than 50% of all cells in three separate experiments.
Discussion
Ovulation is an inflammation-like process that involves increased permeability, leukocyte migration, and follicular tissue edema. In women, there is a massive infiltration of leukocytes into the area surrounding the preovulatory follicle of the ovary, leading to the local accumulation of T lymphocytes, macrophages, and eosinophils in human ovulatory follicles (6) . The attraction of leukocytes from the blood vessels by chemoattractants may involve the local modulation of chemokine expression combined with increased vascular permeability. ␤-Chemokine RANTES, a potent chemoattractant cytokine (20) , may have activity of this type. We detected significant amounts of RANTES protein in follicular fluid and culture supernatants of cells from human preovulatory follicles. mRNA was also detected in cultures by RT-PCR. RANTES production in culture was greatest during the first 24 h. In situ hybridization experiments showed that most of the cells contained mRNA RANTES. More than 50% of the R1-gated cells that were CD45 Ϫ contained RANTES protein at this time. RANTES ϩ cells were also detected in R2 that contained 41-64% CD45 ϩ cells. This proportion had significantly fallen after 48 h in culture. This decrease was probably due to the successive washings, which eliminated suspended leukocytes. Only the macrophages, which were able to adhere to the culture plate, remained in cultures. They were identified immunohistochemically, using the anti-CD68 antibody (29) . Simultaneously, RANTES immunostaining dropped to undetectable levels in R2, suggesting that most of the RANTES production in R2 was attributable to leukocytes, which are a rich in vivo and in vitro sources of RANTES (28) . We also showed that RANTES ϩ cells were always more abundant in R1 than in R2. Furthermore, RANTES production in R1 remained detectable after 48 h, whereas that in R2 dropped after 48 h. Follicular aspirates contained a heterogeneous population of cells, mostly granulosa cells and some leukocytes (30) . Most of the cells contained 3␤HSD activity after 72 h in culture, indicating they were granulosa cells; leukocytes (CD45 ϩ cells) had no 3␤HSD (our unpublished data). These cells were gated in R2 and represented about 10 -30% of the total cells. These findings indicate that most of the ovarian RANTES production at ovulation probably originated from granulosa cells. Leukocytes, which also produce this cytokine, released it in lesser amounts.
Next, we investigated how RANTES production may be regulated. The ovulatory follicle is a site of local inflammation. The hallmark of inflammation is the infiltration of specific leukocyte subsets from the blood into the affected tissue. A variety of chemotactic proteins, including RANTES, orchestrate the migration of leukocytes. Numerous exogenous agents and endogenous proinflammatory stimulants, including the cytokines interleukin-1␤, TNF␣, and interferon-␥, stimulate RANTES production in several cell types (24, 31) . Therefore, RANTES production in the ovulatory follicle may be accounted for by many inflammatory cytokines secreted in follicular fluid. We focused our study on TNF␣. TNF␣ is found in preovulatory follicular fluid (23) ; the effect of TNF␣ on RANTES production has been reported for endothelial cells, which require an exogenous TNF␣ source to produce RANTES (24, 25) ; binding sites for TNF␣ have been previously identified in swine granulo-sa cells (32) . In this study, this cytokine increased the number of cells that stained for RANTES and the amount of RANTES in cultures. Conversely, adding neutralizing anti-TNF␣ antibody abolished RANTES immunostaining in granulosa cells and decreased the amount of RANTES released into the culture supernatants. This finding suggests that endogenous production of TNF␣ was required for the production of RANTES by granulosa cells. TNF p55 receptors were detected by RT-PCR and visualized in granulosa cells by flow cytometry. These receptors may mediate the effects of TNF␣. The possibility that RANTES production is mediated by adenylate cyclase/protein kinase A signal transduction was tested by incubating cells with 8-Br-cAMP. Results suggest that the gonadotropins, which are released in high amounts just before ovulation and act on granulosa cells via an increase in cAMP, probably do not induce RANTES production. On the other hand, PMA increased the number of gran- ulosa cells staining for RANTES. The effect of PMA in granulosa cells is rather complex (33) . PMA is known to activate protein kinase C (PKC) (34) . In contrast, prolonged treatment may also down-regulate phorbol-sensitive isozyme (35) . We previously tested the effect of PMA in human granulosa luteinizing cell cultures; PMA treatment decreased progesterone release by 2-to 3-fold, and this inhibitory effect was antagonized by staurosporine (36) . This finding suggested that PMA activates PKC under our experimental conditions. Signal transduction after TNFR activation may involve PKC (37, 38) . The PKC pathway has been implicated in TNF␣-mediated effects in Leydig cells (39) and ovarian thecal cells (40) . It may also be a critical component in TNF activation of nuclear factor-B (NF-B) (41) . Like PMA, TNF␣ may activate NF-B through PKC (42, 43) . B-like sequences have been identified within RANTES promoter (44) . All of these considerations suggest that TNF␣ may mediate RANTES production in granulosa cells via the activation of PKC and NF-B, although this remains to be demonstrated. Indeed, further experiments quantifying PKC by Western block should be conducted to confirm these data.
TNF␣ is found in preovulatory follicular fluid at concentrations similar to that used in the present study (23) , and this cytokine presumably accounts for RANTES production in the human preovulatory follicle. TNF␣ might directly activate the production of RANTES by granulosa cells via TNFR. In addition, it might induce the production of factors activating RANTES production. Preovulatory events prompt After RT reaction and PCR cycles using oligonucleotide primers corresponding to known complementary DNA sequences for RANTES, the samples were subjected to agarose gel electrophoresis, and the gels were stained with ethidium bromide. Multimers of a 192-bp fragment of DNA characterized the amplification product of RANTES transcripts. massive ovarian infiltration by white blood cells. Paving the way are the mast cells, which play a critical role in initiating the ovulatory process. The preovulatory ovary contains numerous mast cells, and the release of granules from these cells probably initiates the chemotactic response (4). Mast cells alone contain TNF␣ in their granules in a form that they can release immediately (45, 46) . The preovulatory LH surge causes ovarian mast cells to granulate and release histamine and TNF␣. This cytokine may activate RANTES production by granulosa cells. In addition, RANTES is a very potent activator of mast cells and leads to their degranulation (22) . This suggests an autoamplified mechanism between RANTES production and the progression of the ovulatory process. Next to arrive are eosinophils and T lymphocytes, followed in quick succession by the phagocytic monocytes. RANTES is a chemoattractant for these three types of immune cells. It is likely to contribute to their local recruitment. By producing RANTES, granulosa cells may contribute to the influx of immune cells from vessels into the ovulatory follicle, where they accumulate and contribute to the ovulation process and to the formation of the corpus luteum. Further studies identifying RANTES in human ovarian tissues would support these hypotheses.
